Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTK | Q06187 | 1/20 | 0.50 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.47 |
| ▸ | CTSK | P43235 | 2/20 | 0.47 |
| ▸ | GAA | P10253 | 2/20 | 0.45 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.41 |
| ▸ | KDM1A | O60341 | 1/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.41 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.41 |
| ▸ | RELA | Q04206 | 1/20 | 0.41 |
| ▸ | REN | P00797 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.39 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL48274 | 1.00 | BTK (0.50) | BTKEPHX2CTSKGAACA1 | |
| SCHEMBL25306007 | 1.00 | BTK (0.50) | BTKEPHX2CTSKGAACA1 | |
| SCHEMBL133307 | 1.00 | BTK (0.50) | BTKEPHX2CTSKGAACA1 | |
| SCHEMBL25306009 | 1.00 | BTK (0.50) | BTKEPHX2CTSKGAACA1 | |
| Hydrochloric Acid SCHEMBL30563288 | 0.98 | BTK (0.49) | BTKEPHX2CTSKGAACA1 | |
| Hydrochloric Acid SCHEMBL27995727 | 0.98 | BTK (0.49) | BTKEPHX2CTSKGAACA1 | |
| Hydrochloric Acid SCHEMBL31088698 | 0.98 | BTK (0.49) | BTKEPHX2CTSKGAACA1 | |
| Bicarbonate SCHEMBL48015 | 0.97 | BTK (0.51) | BTKEPHX2CTSKGAACA1 | |
| SCHEMBL1412188 | 0.92 | EPHX1 (0.51) | BTKEPHX2CTSKGAACA1 | |
| SCHEMBL8960563 | 0.92 | EPHX1 (0.51) | BTKEPHX2CTSKGAACA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2405 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115160310-B | Alternanthene derivatives as CDK2/Topo I inhibitors, preparation method thereof and antitumor application thereof | 中国人民解放军北部战区总医院 | 2023-06-23 | — | — | CN | claimed |
| CN-115160298-B | Tacrine-sulfonamide derivative and preparation method and application thereof | 中国人民解放军北部战区总医院 | 2023-05-23 | — | — | CN | claimed |
| CN-115160310-A | Sinomenine derivatives as CDK2/Topo I inhibitor, and preparation method and anti-tumor application thereof | 中国人民解放军北部战区总医院 | 2022-10-11 | — | — | CN | claimed |
| CN-115160298-A | Tacrine-sulfonamide derivative and preparation method and application thereof | 中国人民解放军北部战区总医院 | 2022-10-11 | — | — | CN | claimed |
| CN-115124511-A | Tacrine derivative, preparation method thereof and application of tacrine derivative as CDK2/9 inhibitor | 中国人民解放军北部战区总医院 | 2022-09-30 | — | — | CN | claimed |
| CN-114573563-A | Bifunctional molecular compound for inducing PD-L1 protein degradation and preparation and application thereof | 沈阳药科大学 | 2022-06-03 | — | — | CN | claimed |
| CN-114394921-A | Preparation method of high-purity brivaracetam | 浙江九洲药业股份有限公司 | 2022-04-26 | — | — | CN | claimed |
| EP-4747234-A1 | KV1.3 POTASSIUM CHANNEL ANTAGONISTS | Muna Therapeutics ApS (DK) | 2026-05-27 | — | — | EP | disclosed |
| CN-119707952-B | Thiadiazolidinone derivative with PTPN2/PTPN1 inhibitory activity, and preparation method and application thereof | CHINA PHARMACEUTICAL UNIVERSITY (CN) | 2026-05-26 | — | — | CN | disclosed |
| WO-2026106389-A1 | NMT INHIBITOR AND USE THEREOF | 주식회사 이노보테라퓨틱스 | 2026-05-21 | — | — | WO | disclosed |
| EP-4743462-A1 | COMPOUNDS COMPRISING A NAPHTHYRIDINE OR PYRIDOPYRIMIDINE CORE AS PTC READ-THROUGH AGENTS | Tay Therapeutics Limited (GB) | 2026-05-20 | — | — | EP | disclosed |
| US-12630511-B2 | Benzamide derivative, preparation method therefor, and pharmaceutical composition comprising same as active ingredient for prevention or treatment of cancer | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2026-05-19 | — | — | US | disclosed |
| EP-4739685-A1 | 1,6-NAPHTHRIDINE COMPOUNDS AS SMARCA2 INHIBITORS USEFUL FOR THE TREATMENT OF SMARCA4 DEFICIENT CANCERS | Janssen Pharmaceutica NV (BE) | 2026-05-13 | — | — | EP | disclosed |
| EP-0465716-A1 | Optically active thiazetoquino-line-3-carboxylic acid compound, method for preparation thereof, and a pharmaceutical composition comprising the same | HOKURIKU PHARMACEUTICAL CO., LTD. (JP) | 1992-01-15 | — | — | EP | disclosed |
| EP-0394685-A2 | (S)-7-(3-Amino-1-pyrrolidinyl)-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid | WARNER-LAMBERT COMPANY (US) | 1990-10-31 | — | — | EP | disclosed |
| EP-0393538-A2 | Thiazetoquinoline-3-Carboxylic acid derivative, method for preparation thereof, and a pharmaceutical composition comprising the same | HOKURIKU PHARMACEUTICAL CO., LTD. (JP) | 1990-10-24 | — | — | EP | disclosed |
| EP-0391169-A2 | Enantiomeric pure 7-(3-amino-1-pyrrolidinyl)-chinolon-and-naphthyridon carboxylic acids | BAYER AG (DE) | 1990-10-10 | — | — | EP | disclosed |
| US-4916141-A | ANTIBACTERIAL | WARNER-LAMBERT COMPANY (US) | 1990-04-10 | — | — | US | disclosed |
| US-4851418-A | Naphthyridine antibacterial agents containing an α-amino acid in the side chain of the 7-substituent | WARNER-LAMBERT COMPANY (US) | 1989-07-25 | — | — | US | disclosed |
| EP-0304087-A2 | Quinolone and naphthyridine antibacterial agents containing an alpha-amino acid in the side chain of the 7-substituent | WARNER-LAMBERT COMPANY (US) | 1989-02-22 | — | — | EP | disclosed |